A detailed history of Fmr LLC transactions in Rezolute, Inc. stock. As of the latest transaction made, Fmr LLC holds 12,811,876 shares of RZLT stock, worth $113 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
12,811,876
Previous 6,507,718 96.87%
Holding current value
$113 Million
Previous $18.9 Million 202.78%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

BUY
$2.47 - $4.46 $15.6 Million - $28.1 Million
6,304,158 Added 96.87%
12,811,876 $57.1 Million
Q1 2025

May 12, 2025

BUY
$2.73 - $5.57 $17.8 Million - $36.2 Million
6,507,718 New
6,507,718 $18.9 Million
Q2 2023

Aug 11, 2023

BUY
$1.75 - $2.33 $11,375 - $15,145
6,500 Added 32.18%
26,700 $52,000
Q1 2023

May 11, 2023

BUY
$1.79 - $2.87 $36,158 - $57,974
20,200 New
20,200 $38,000

Others Institutions Holding RZLT

About Rezolute, Inc.


  • Ticker RZLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,600
  • Market Cap $342M
  • Description
  • Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...
More about RZLT
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.